Evicenter
Leqvio (inclisiran) in Hypercholesterolemia
Manufacturer
Novartis Pharmaceuticals Corporation
Prescribing information
Leqvio (opens in a new tab)
Questions
17
Last updated

All questions

Guidelines: Leqvio (inclisiran) in hypercholesterolemia

2 questions · 1 source

Guidelines

What LDL-C targets does the 2026 guideline set (Leqvio site)?

Note: The Leqvio HCP site attributes these statements to the 2026 ACC/AHA multisociety guideline on the management of dyslipidemia (Blumenthal et al., Circulation, 2026). The targets are guideline recommendations for patients with ASCVD.

When does the 2026 guideline recommend rechecking lipids (Leqvio site)?

Note: The guideline statement, as summarized on the Leqvio HCP site, applies to lipid-lowering therapy in general. For Leqvio itself, the Prescribing Information states that the LDL-lowering effect may be measured as early as 30 days after initiation (see the question on checking LDL-C).